首頁 > 市場調查報告書 > 消費品

健康美容口腔衛生

市場調查報告書

商品編碼

2075458

細菌性涎腺炎市場：按類型、細菌類型、腺體類型、藥物類別、分銷管道和地區分類

Bacterial Sialadenitis Market, By Type, By Type of Bacteria, By Gland Type, By Drug Class, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細菌性涎腺炎市場預計在 2026 年達到 5.722 億美元，預計到 2033 年將達到 8.214 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.3%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	5.722億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	5.30%	預計金額（2033 年）	8.214億美元

全球細菌性涎腺炎市場涵蓋急性、慢性及類似類別的產品。這些產品針對金黃色葡萄球菌、草綠色鏈球菌和綠膿桿菌等致病菌，廣泛應用於醫院、藥局和零售藥局。隨著各機構日益重視療效、效率和成本效益，這些產品在這些領域的應用也持續穩定成長。

市場動態：

醫院、藥局和零售藥局需求的成長，對提高效率和可靠性的需求，以及持續的產品創新，預計將是推動全球細菌性涎腺炎市場成長的主要因素。針對金黃色葡萄球菌和草綠色鏈球菌的應用範圍不斷擴大，進一步加速了這一成長動能。

例如，市場參與者正在實施針對金黃色葡萄球菌感染案例而設計的先進解決方案。此外，預計在預測期內，持續的技術進步和策略投資將為市場參與者創造新的成長機會。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本頁面根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球細菌性唾液腺炎市場的主要公司進行了介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球細菌性涎腺炎市場》報告是針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球細菌性涎腺炎市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 南非
- 中非

第11章競爭格局

Pfizer Inc.
Merck & Co., Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi SA
Johnson & Johnson
Abbott Laboratories
Eli Lilly and Company
AstraZeneca plc.
Bayer AG

第12章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI5810

Bacterial Sialadenitis Market is estimated to be valued at USD 572.2 Mn in 2026 and is expected to reach USD 821.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 572.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.30%	2033 Value Projection:	USD 821.4 Mn

The global bacterial sialadenitis market includes offerings that span Acute and Chronic, and similar type categories. These are applied across Staphylococcus aureus, Streptococcus viridans, and Pseudomonas aeruginosa and adopted by Hospitals Pharmacies, and Retail Pharmacies. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.

Market Dynamics:

Increasing demand from Hospitals Pharmacies, and Retail Pharmacies, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global bacterial sialadenitis market. Broader adoption across Staphylococcus aureus, and Streptococcus viridans is reinforcing this momentum.

For instance, market players are introducing advanced solutions designed for Staphylococcus aureus use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global bacterial sialadenitis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer Inc., Merck & Co, Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market.

Detailed Segmentation:

Global Bacterial Sialadenitis Market, By Type (Revenue, USD Bn, 2021 - 2033)
Acute and Chronic
Global Bacterial Sialadenitis Market, By Type of Bacteria (Revenue, USD Bn, 2021 - 2033)
Staphylococcus aureus
Streptococcus viridans
Pseudomonas aeruginosa
Escherichia coli
Others
Global Bacterial Sialadenitis Market, By Gland Type (Revenue, USD Bn, 2021 - 2033)
Parotid
Submandibular
Sublingual
Global Bacterial Sialadenitis Market, By Drug Class (Revenue, USD Bn, 2021 - 2033)
Antibiotics and Analgesics
Global Bacterial Sialadenitis Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospitals Pharmacies
Retail Pharmacies
Ecommerce
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Pfizer Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Merck & Co, Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi S.A.
Johnson & Johnson
Abbott Laboratories
Eli Lilly and Company
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Roche Holding AG
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Allergan plc

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bacterial Sialadenitis Market, By Type
- Market Bacterial Sialadenitis Market, By Type of Bacteria
- Market Bacterial Sialadenitis Market, By Gland Type
- Market Bacterial Sialadenitis Market, By Drug Class
- Market Bacterial Sialadenitis Market, By Distribution Channel
- Market Bacterial Sialadenitis Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Merger and Acquisition Scenario

4. Bacterial Sialadenitis

Supply Side and Demand Side Analysis
Economic Impact

5. Bacterial Sialadenitis Market, By Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Bacterial Sialadenitis Market, By Type of Bacteria, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Streptococcus viridans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Bacterial Sialadenitis Market, By Gland Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
Paratoid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Submandibular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

8. Bacterial Sialadenitis Market, By Drug Class, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  - Dicloxacillin
  - Cephalosporin
  - Clindamycin
- Analgesic
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

9. Bacterial Sialadenitis Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Ecommerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

10. Bacterial Sialadenitis Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022€"2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Mn)
  - North Africa
  - South Africa
  - Central Africa

11. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views